Is age a risk factor for cognitive changes following hematopoietic cell transplantation?

• Published in: Bone marrow transplantation (Basingstoke) Vol. 56; no. 3; pp. 567 - 569
• Main Authors: Stratton, John, Sylvia, Allison, Hoodin, Flora, Choi, Sung Won, Pawarode, Attaphol, Giordani, Bruno, Votruba, Kristen
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.03.2021; Nature Publishing Group
• Subjects: 631/67/1990; 692/700/784; 96/100; Age; Age factors; Age factors in disease; Autografts; Cell Biology; Cognition; Cognition & reasoning; Cognition disorders; Cognitive ability; Demographic aspects; Hematology; Hematopoietic stem cells; Internal Medicine; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Performance prediction; Public Health; Regression analysis; Reorganization and restructuring; Risk analysis; Risk factors; Statistical analysis; Stem cell transplantation; Stem Cells; Transplantation; Transplants & implants; United States
• ISSN: 0268-3369; 1476-5365
• DOI: 10.1038/s41409-020-01046-3

Cognitive deficits following hematopoietic cell transplantation (HCT) are common and affect post-HCT treatment regimen adherence and quality-of-life. Little is known about effects of age on cognition following HCT. The current study aimed to identify the effects of age on cognition one-year post-HCT, compared to pre-HCT baseline functioning. Participants were 78 autologous and allogeneic transplant recipients who underwent neuropsychological assessments at baseline and one-year post-HCT. Mixed model analyses indicated that no statistically significant main effect of age was observed for any cognitive variable. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Total Index Score and Trail Making Test (parts A and B) showed significant interaction effects between age and transplant type. These findings indicate that older autologous and allogeneic transplant recipients were predicted to perform similarly; however, young allogeneic HCT recipients were predicted to perform substantially below young autologous transplant recipients. Hierarchical regressions indicated that age failed to predict changes in neuropsychological test performance between baseline and one-year post-HCT. These findings indicate that advanced age may not be a risk factor for worse cognitive outcome post-HCT, though younger allogeneic transplant recipients may be at risk for worse cognitive outcomes, relative to younger autologous recipient counterparts. Clinical implications are discussed.